Dermatitis atopic
Not yet recruitingStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
- Disease:Dermatitis atopic
- Substances:Img-007
Czechia- Participants:18–64 years · 65+ years
- Substances:Img-007
- Sponsor:Inmagene LLC
Rare diseases
Investigational molecules
Locations
.png)
12526 High Bluff Drive Ste 345, 92130-3015, United States
Inmagene LLC focuses its clinical research on atopic dermatitis, with an emphasis on adult patients living with moderate-to-severe disease. Its studies examine treatment effects on eczema burden and clinical signs of skin inflammation.
The sponsor’s research activity in this area reflects a concentrated interest in dermatologic conditions where control of disease activity and symptom reduction are central therapeutic goals.
Inmagene LLC runs clinical trials in conditions such as Dermatitis atopic, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Czechia
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.